Dr. Kazemi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2305 Camino Ramon
Suite 270
San Ramon, CA 94583Phone+1 925-866-8700Fax+1 925-866-8701- Is this information wrong?
Education & Training
University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 2002 - 2006- University of California (San Francisco)Residency, Internal Medicine, 2000 - 2003
- University of California San Francisco School of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2002 - 2026
NJ State Medical License 2021 - 2025- National Board of Physicians and Surgeons Endocrinology Diabetes and Metabolism
- National Board of Physicians and Surgeons Internal Medicine
Awards, Honors, & Recognition
- Most Compassionate Doctor American Registry
Publications & Presentations
PubMed
- 24 citationsHypoglycemia After Initiation of Basal Insulin in Patients with Type 2 Diabetes in the United States: Implications for Treatment Discontinuation and Healthcare Costs a...Mehul Dalal, Mahmood R. Kazemi, Fen Ye, Lin Xie> ;Advances in Therapy. 2017 Aug 4
- 12 citationsAchieve control: a pragmatic clinical trial of insulin glargine 300 U/mL versus other basal insulins in insulin-naïve patients with type 2 diabetesGerry Oster, Sean D. Sullivan, Mehul Dalal, Mahmood R. Kazemi, Maria Rojeski, Carol Wysham, Jennifer Sung, Bryan Johnstone, Anna M. G. Cali, L.J. Wei, Louise Traylor, ...> ;Postgraduate Medicine. 2016 Oct 24
- 11 citationsHypoglycemia in patients with type 2 diabetes newly initiated on basal insulin in the US in a community setting: impact on treatment discontinuation and hospitalizationMehul Dalal, Mahmood R. Kazemi, Fen Ye> ;Current Medical Research and Opinion. 2017 Feb 1
- Join now to see all
Authored Content
- Mahmood Kazemi: A Remote Revolution in Diabetes CareNovember 2020
Press Mentions
Abbott Reports Positive Data from FreeStyle Libre 2 System TrialOctober 7th, 2022- ADA: Abbott's FreeStyle Libre 3 Scores Highest Accuracy for a 14-Day CGM in Clinical TrialJune 6th, 2022
- Late-Breaking Data Demonstrate Abbott’s FreeStyle Libre® 3 System Is Most Accurate 14-Day Continuous Glucose MonitorJune 5th, 2022
- Join now to see all
Professional Memberships
- Member
Other Languages
- French, Farsi
Hospital Affiliations
Good Samaritan HospitalSan Jose, California
San Francisco VA Medical CenterSan Francisco, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
